Free Trial

Boston Scientific (BSX) Earnings Date, Estimates & Call Transcripts

Boston Scientific logo
$86.99 -0.60 (-0.69%)
(As of 11/15/2024 ET)

Boston Scientific Latest Earnings Summary

Upcoming Q4
Earnings Date
Jan. 29Estimated
Actual EPS
(Oct. 23)
$0.63 Beat By $0.04
Consensus EPS
(Oct. 23)
$0.59

Boston Scientific issued Q3 2024 earnings on October 23, 2024, reporting an EPS of $0.63, which topped the consensus estimate of $0.59 by $0.04. Quarterly revenue rose 19.3% year-over-year to $4.21 billion, above analysts' expectations of $4.04 billion. With a trailing EPS of $1.21 and a P/E Ratio of 71.89, Boston Scientific's earnings are expected to grow 10.57% next year, from $2.46 to $2.72 per share.

BSX Upcoming Earnings

Boston Scientific's next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules.

Get Boston Scientific Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Boston Scientific and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BSX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BSX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Boston Scientific Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.52$0.52$0.520.500 - 0.520
Q2 20241$0.56$0.56$0.560.570 - 0.590
Q3 20241$0.54$0.54$0.540.570 - 0.590
Q4 20241$0.58$0.58$0.580.640 - 0.660
FY 20244$2.20$2.20$2.20 
Q1 20251$0.63$0.63$0.63 
Q2 20251$0.61$0.61$0.61 
Q3 20251$0.62$0.62$0.62 

Boston Scientific Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
1/29/2025
(Estimated)
------- 
10/23/2024Q3 2024$0.59$0.63+$0.04$0.94$4.04B$4.21B        
7/24/2024Q2 2024$0.58$0.62+$0.04$1.02$4.02B$4.12B        
4/24/2024Q1 2024$0.51$0.56+$0.05$0.79$3.68B$3.86B    
1/31/2024Q4 2023$0.51$0.55+$0.04$0.76$3.59B$3.73B        
10/26/2023Q3 2023$0.48$0.50+$0.02$0.66$3.48B$3.53B        
7/27/2023Q2 2023$0.49$0.53+$0.04$0.88$3.50B$3.60B        
4/26/2023Q1 2023$0.43$0.47+$0.04$0.73$3.16B$3.39B        
2/1/2023Q4 2022$0.47$0.45 -$0.02$0.81$3.24B$3.24B        

Boston Scientific Earnings - Frequently Asked Questions

Boston Scientific has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on BSX's earnings history.

Boston Scientific issued an update on its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided EPS guidance of $0.64-$0.66 for the period, compared to the consensus EPS estimate of $0.64. The company issued revenue guidance of $4.34-$4.41 billion, compared to the consensus revenue estimate of $4.28 billion.

In the previous quarter, Boston Scientific (NYSE:BSX) reported $0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $0.59 by $0.04. Learn more on analysts' earnings estimate vs. BSX's actual earnings.

The conference call for Boston Scientific's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Boston Scientific's latest earnings report can be read online.
Read Transcript

Boston Scientific (NYSE:BSX) has a recorded annual revenue of $14.24 billion.

Boston Scientific (NYSE:BSX) has a recorded net income of $1.59 billion. BSX has generated $1.21 earnings per share over the last four quarters.

Boston Scientific (NYSE:BSX) has a trailing price-to-earnings ratio of 71.89 and a forward price-to-earnings ratio of 35.36. The price/earnings-to-growth ratio is 2.61.

Boston Scientific's earnings are expected to grow from $2.46 per share to $2.72 per share in the next year, which is a 10.57% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:BSX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners